Danazol and its principal metabolites interfere with binding of testosterone, cortisol, and thyroxin by plasma proteins

9Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

Danazol and its three principal metabolites (2-hydroxymethylethisterone, 2-hydroxymethyl-1,2-dehydroethisterone, and ethisterone) competitively displace cortisol and testosterone from plasma proteins. The effect is in addition to the reported inhibition of the production of testosterone-binding globulin and thyroxin-binding globulin. We saw no competitive inhibition of thyroxin binding. Concentrations of total testosterone, total cortisol, and total thyroxin were low, whereas percentages of free testosterone, free cortisol, and free thyroxin were abnormally high in women being treated with danazol. Values for testosterone, cortisol, and thyroxin in danazol-treated patients should therefore be appropriately corrected before interpretation. Protein-binding assays for testosterone or cortisol that involve testosterone- or cortisol-binding globulin may be invalid in danazol-treated subjects because of the competitive binding of danazol and its metabolites to these proteins.

Cite

CITATION STYLE

APA

Haning, R. V., Carlson, I. H., Cortes, J., Nolten, W. E., & Meier, S. (1982). Danazol and its principal metabolites interfere with binding of testosterone, cortisol, and thyroxin by plasma proteins. Clinical Chemistry, 28(4 I), 696–698. https://doi.org/10.1093/clinchem/28.4.696

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free